Differential ferritin expression is associated with iron deficiency in coeliac disease

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 7, 2009, Pages 794-804

  Sharma, Naveen ^a   Begum, Jusnara ^a   Eksteen, Bertus ^a   Elagib, Amul ^a   Brookes, Matthew ^a   Cooper, Brian T ^b   Tselepis, Chris ^a   Iqbal, Tariq H ^c,d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Coeliac disease; Divalent metal transporter 1; Ferritin; Iron; Tumour necrosis factor

Indexed keywords

FERRITIN; FERROPORTIN; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTICLE; CELIAC DISEASE; CELL STRAIN CACO 2; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM BIOPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CELL; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON TRANSPORT; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION;

ANEMIA, IRON-DEFICIENCY; CATION TRANSPORT PROTEINS; CELIAC DISEASE; ENTEROCYTES; FEMALE; FERRITINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL ABSORPTION; MALE; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 67651068788     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328308676b     Document Type: Article

References (42)

1. Kagnoff MF. Overview and pathogenesis of celiac disease. Gastroenterology 2005; 128:S10-S18.
2. AGA Institute. AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology 2006; 131:1977-1980. (Pubitemid 44958522)
3. Karell K, Louka AS, Moodie SJ, Ascher H, Clot F, Greco L, et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003; 64:469-477. (Pubitemid 36373778)
4. Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 2003; 61:105-117.
5. Kagnoff MF. Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest 2007; 117:41-49. (Pubitemid 46048448)
6. Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003; 348:2517-2524. (Pubitemid 36706539)
7. West J, Logan RF, Hill PG, Lloyd A, Lewis S, Hubbard R, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003; 52:960-965. (Pubitemid 36765286)
8. Logan RF, Tucker G, Rifkind EA, Heading RC, Ferguson A. Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-1979. Br Med J (Clin Res Ed) 1983; 286:95-97.
9. Green PH. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology 2005; 128:S74-S78. (Pubitemid 40460825)
10. Ciclitira PJ, King AL, Fraser JS. AGA technical review on celiac sprue. American Gastroenterological Association. Gastroenterology 2001; 120:1526-1540. (Pubitemid 32322327)
11. Jones S, D'Souza C, Haboubi NY. Patterns of clinical presentation of adult coeliac disease in a rural setting. Nutr J 2006; 5:24. (Pubitemid 44440837)
12. Sanders DS, Hurlstone DP, Stokes RO, Rashid F, Milford-Ward A, Hadjivassiliou M, et al. Changing face of adult coeliac disease: experience of a single university hospital in south Yorkshire. Postgrad Med J 2002; 78:31-33. (Pubitemid 34074912)
13. Sharma N, Butterworth J, Cooper BT, Tselepis C, Iqbal TH. The emerging role of the liver in iron metabolism. Am J Gastroenterol 2005; 100:201-206. (Pubitemid 41623289)
14. Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol 2007; 69:69-85.
15. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388:482-488. (Pubitemid 27328927)
16. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000; 403:776-781. (Pubitemid 30111839)
17. Morgan EH, Oates PS. Mechanisms and regulation of intestinal iron absorption. Blood Cells Mol Dis 2002; 29:384-399.
18. Laftah AH, Sharma N, Brookes MJ, McKie AT, Simpson RJ, Iqbal TH, Tselepis C. Tumour necrosis factor alpha causes hypoferraemia and reduced intestinal iron absorption in mice. Biochem J 2006; 397:61-67. (Pubitemid 44032837)
19. Sharma N, Laftah AH, Brookes MJ, Cooper B, Iqbal T, Tselepis C. A role for tumour necrosis factor alpha in human small bowel iron transport. Biochem J 2005; 390:437-446. (Pubitemid 41337105)
20. O'Keeffe J, Lynch S,Whelan A, Jackson J, Kennedy NP,Weir DG, et al. Flow cytometric measurement of intracellular migration inhibition factor and tumour necrosis factor alpha in the mucosa of patients with coeliac disease. Clin Exp Immunol 2001; 125:376-382. (Pubitemid 34155433)
21. Dewar D, Pereira SP, Ciclitira PJ. The pathogenesis of coeliac disease. Int J Biochem Cell Biol 2004; 36:17-24.
22. Di Martino E,Wild CP, Rotimi O, Darnton JS, Olliver RJ, Hardie LJ. IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett's oesophagus and associated oesophageal adenocarcinoma: potential biomarkers of disease risk. Biomarkers 2006; 11:547-561. (Pubitemid 44614826)
23. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004; 21:527-538. (Pubitemid 39370508)
24. Barisani D, Parafioriti A, Bardella MT, Zoller H, Conte D, Armiraglio E, et al. Adaptive changes of duodenal iron transport proteins in celiac disease. Physiol Genomics 2004; 17:316-325. (Pubitemid 38924177)
25. Feelders RA, Vreugdenhil G, Eggermont AM, Kuiper-Kramer PA, van Eijk HG, Swaak AJ. Regulation of iron metabolism in the acute-phase response: interferon gamma and tumour necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients. Eur J Clin Invest 1998; 28:520-527. (Pubitemid 28350015)
26. Ludwiczek S, Aigner E, Theurl I, Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 2003; 101:4148-4154. (Pubitemid 36857898)
27. Torti SV, Kwak EL, Miller SC, Miller LL, Ringold GM, Myambo KB, et al. The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J Biol Chem 1988; 263:12638-12644.
28. Miller LL, Miller SC, Torti SV, Tsuji Y, Torti FM. Iron-independent induction of ferritin H chain by tumor necrosis factor. Proc Natl Acad Sci U S A 1991; 88:4946-4950. (Pubitemid 21914660)
29. Kwak EL, Larochelle DA, Beaumont C, Torti SV, Torti FM. Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem 1995; 270:15285-15293.
30. Johnson D, Bayele H, Johnston K, Tennant J, Srai SK, Sharp P. Tumour necrosis factor alpha regulates iron transport and transporter expression in human intestinal epithelial cells. FEBS Lett 2004; 573:195-201. (Pubitemid 39141057)
31. Nilsen EM, Lundin KE, Krajci P, Scott H, Sollid LM, Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 1995; 37: 766-776.
32. Chaudhary R, Ghosh S. Infliximab in refractory coeliac disease. Eur J Gastroenterol Hepatol 2005; 17:603-604.
33. Gillett HR, Arnott ID, McIntyre M, Campbell S, Dahele A, Priest M, Jackson R, Ghosh S. Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 2002; 122:800-805. (Pubitemid 34173833)
34. Turner SM, Moorghen M, Probert CS. Refractory coeliac disease: remission with infliximab and immunomodulators. Eur J Gastroenterol Hepatol 2005; 17:667-669. (Pubitemid 40733815)
35. McManus R,Wilson AG, Mansfield J,Weir DG, Duff GW, Kelleher D. TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur J Immunol 1996; 26:2113-2118. (Pubitemid 26297510)
36. Garrote JA, Arranz E, Telleria JJ, Castro J, Calvo C, Blanco-Quiros A. TNF alpha and LT alpha gene polymorphisms as additional markers of celiac disease susceptibility in a DQ2-positive population. Immunogenetics 2002; 54:551-555. (Pubitemid 35435513)
37. Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G. The NF-kappaB-mediated control of ROS and JNK signaling. Histol Histopathol 2006; 21:69-80. (Pubitemid 43033716)
38. Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, et al. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 2004; 119:529-542. (Pubitemid 39482352)
39. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG. Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis. Rheumatol Int 2006; 27:157-161.
40. Scaccabarozzi A, Arosio P, Weiss G, Valenti L, Dongiovanni P, Fracanzani AL, et al. Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells. Br J Haematol 2000; 110:978-984. (Pubitemid 30804494)
41. Ten Elshof AE, Brittenham GM, Chorney KA, Page MJ, Gerhard G, Cable EE, et al. Gamma delta intraepithelial lymphocytes drive tumor necrosis factor-alpha responsiveness to intestinal iron challenge: relevance to hemochromatosis. Immunol Rev 1999; 167:223-232. (Pubitemid 29178984)
42. Meyer PN, Gerhard GS, Yoshida Y, Yoshida M, Chorney KA, Beard J, et al. Hemochromatosis protein (HFE) and tumor necrosis factor receptor 2 (TNFR2) influence tissue iron levels: elements of a common gut pathway? Blood Cells Mol Dis 2002; 29:274-285.